HS-201 (Solid Malignancies)

What is the Purpose of this Study?

If you choose to join this study you will:
-Have the the study drug (HS-201) given into your vein the day before your surgery.
-Have a small amount of tissue taken out during your surgery

One month after your surgery you will:
-Have a physical exam
-Answer questions about how you are feeling after your surgery
-Give blood samples
What is the Condition Being Studied?
Solid Malignancies (cells with cancer)

Who Can Participate in this Study?

-Adults

-Diagnosis of a solid malignancy

-Planned surgical removal or biopsy of cancerous cells

Age Group
Adults
Participating Institutions

What is Involved?

We are doing this study to see how much of the study drug (an imaging agent called HS-201) is needed to mark cancer cells and help doctors to see cancer during and after surgery.

Study Details

Full Title
A PHASE I STUDY OF HS-201, AN HSP90 INHIBITOR-LINKED VERTEPORFIN FOR DETECTION OF SOLID MALIGNANCIES
Principal Investigator
Herbert Lyerly
George Barth Geller Distinguished Professor of Immunology

Contacts
Protocol Number
IRB:
PRO00102188

NCT:
NCT03906643
ClinicalTrials.gov
View on ClinicalTrials.gov